Clinical Trials Logo

Nocturnal Myoclonus Syndrome clinical trials

View clinical trials related to Nocturnal Myoclonus Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT04816136 Completed - Ischemic Stroke Clinical Trials

Consequences of Post Stroke Polysomnographic Abnormalities on Functionnal Recovery and Survival After an Ischemic Stroke

PSG-AVC
Start date: January 1, 2002
Phase:
Study type: Observational

Ischemic stroke is a major public health issue, likely to cause functional disability. It is well known that sleep has an impact on brain plasticity, and after an ischemic stroke, studies have shown subjective sleep quality alterations and sleep architecture abnormalities. Furthermore, there is no clear guideline showing the usefulness of a systematic sleep investigation following an ischemic stroke. The aim of the study is to identify retrospectively correlation between polysomnographic abnormalities (sleep apnea, periodic limb movements, disturbed sleep architecture…) and functional recovery after an ischemic stroke. The study also assesses the impact of sleep abnormalities on survival, and the risk of new cardiovascular event.

NCT ID: NCT04618978 Recruiting - Clinical trials for Spinal Cord Injuries

Periodic Leg Movements' Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?

ACTI-MPJ-BM
Start date: February 25, 2021
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT04610827 Terminated - Sleep Disorder Clinical Trials

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

Start date: November 16, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.

NCT ID: NCT04569643 Enrolling by invitation - Clinical trials for Cognitive Dysfunction

Periodic Limb Movement Syndrome in Patients With Cerebral Small Vessel Disease.

Start date: December 1, 2020
Phase:
Study type: Observational

Patients from 60 to 75 years old diagnosed with cerebral small vessel disease with no history of symptomatic stroke, brain tumor, traumatic brain injury, seizures and neurodegenerative or mental disorder will undergo overnight leg actigraphy and cardiorespiratory monitoring. Those of them with apnea/hypopnea index under 5 will be enrolled. Brain MRI and cognitive assessment will be performed at baseline and in 1-year follow-up, sleep quality will be assessed at baseline with self-reported questionnaires. Progression of cerebral small vessel disease markers and cognitive dysfunction will be compared between patients with high periodic limb movement index (the number of periodic limb movement ≥ 15 per hour of sleep) and controls (periodic limb movement index < 15/h).

NCT ID: NCT03383354 Active, not recruiting - Cancer Clinical Trials

The Link Between Clinical and Physiological Sleep Data and Health-related Outcomes

Start date: January 1, 2004
Phase:
Study type: Observational
Read more »